Table 3.

Estimated $C_1$, $\mathit{\alpha }$ parameters for human myocardium from previous studies

Case	$C_1$ (Pa)	$\mathit{\alpha }$	$|\mathrm{\Delta }\mathit{u}|$ (mm)
Human
Healthy${}^{\mathrm{a}}$	${2000}^{\mathrm{e}}$	43	1.78
Patient 1${}^{\mathrm{a}}$	${2000}^{\mathrm{e}}$	105	1.58
Patient 2${}^{\mathrm{a}}$	${2000}^{\mathrm{e}}$	95	1.39
Healthy${}^{\mathrm{b}}$	$3600\pm {1200}^{\mathrm{e}}$	38	–
HT${}^{\mathrm{b},\mathrm{c}}$	$12000\pm {2600}^{\mathrm{e}}$	38	–
NI-HF${}^{\mathrm{b},\mathrm{d}}$	$11800\pm {3400}^{\mathrm{e}}$	38	–

${}^{\mathrm{a}}$ Xi et al. (2013). ${}^{\mathrm{b}}$Wang et al. (2013). ${}^{\mathrm{c}}$ Patients with hypertrophic LV. ${}^{\mathrm{d}}$ Patients with non-ischaemic HF with reduced EF. ${}^{\mathrm{e}}$ In these studies the scaling constant is defined as half the $C_1$ parameter in Eq. 1, and therefore, values reported here have been doubled for consistency in the results